Ireps

AOC

Goods

Ranibizumab 2.3mg Inj (Approved by CDSCO for all six indications as 1)Wet AMD, 2)Diabetic Macular Edema, 3)Retinal Vein Occlusion, 4)Myopic CNVM, 5)Proliferative Diabetic Retinopathy, 6)Retinopathy of Prematurity)

Unknown (Unspecified Location) | Gujarat | Madhya Pradesh | Maharashtra

Amount: Refer DocsCloses: 18 May 2026Closed

Bids

1 Bid14 Jun 2026

#	Company	Amount
1	₹17.2 L	₹17.2 L

Tender Value

Refer Docs

EMD Value

₹60,900

Closing Date

18 May 2026, 11:00 amClosed

Work Description

Ranibizumab 2.3mg Inj (Approved by CDSCO for all six indications as 1)Wet AMD, 2)Diabetic Macular Edema, 3)Retinal Vein Occlusion, 4)Myopic CNVM, 5)Proliferative Diabetic Retinopathy, 6)Retinopathy of Prematurity)

Tender Information

Tender ID

28262558

Reference Number

28262558

Tender Type

Limited - Indigenous

Location

Unknown (Unspecified Location)

Source Website

Subscribe to view

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

₹60,900

Important Dates

Last Activity

23 Apr 2026

Published

23 Apr 2026

BOQ Preview

•

Description :Ranibizumab 2.3mg Inj (Approved by CDSCO for all six indications as 1)Wet AMD, 2)Dia betic Macular Edema, 3)Retinal Vein Occlusion, 4)Myopic CNVM, 5)Proliferative Diabetic Retinopathy, 6)Retinopathy of Prematurity) ] Divisional Rly Hosp ADI WR, WR Gujarat 20.00 Numbers Divisional Rly Hosp PRTN WR, Gujarat 50.00 Numbers WR Consignee Divisional Rly Hosp RJT WR, WR Gujarat 15.00 Numbers Divisional Rly Hosp RTM WR, WR Madhya Pradesh 24.00 Numbers Jagjivan Ram Hospital, WR Maharashtra 200.00 Numbers

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

HTML

NIT Documents

nit.pdf

NIT

Work Item Documents

5037803.pdf

ATTACHMENT

5047457.pdf

ATTACHMENT

4803751.pdf

ATTACHMENT

5615594.pdf

ATTACHMENT

Ready to Participate?

Download all tender documents and submit your bid